THAR
THAR
NASDAQ · Biotechnology

Tharimmune Inc

$4.07
-0.13 (-2.98%)
THAR vs Biotechnology Average
Profit Margin
THAR 3.6%
Avg -192.1%
Rev Growth
THAR +0.4%
Avg +12.8%

Biotechnology Peers

1013 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
THAR Tharimmune Inc $4.07 -2.98% 187.37M — 3.6% +0.4% — Current
ABBV Abbvie Inc $292.82 -0.59% 520.47B 50.3 6.9% +1.8% 4.47% Strong buy Compare
AMGN Amgen Inc $457.93 -0.95% 252.64B 26.9 21.0% +11.8% 3.21% Hold Compare
GILD Gilead Sciences Inc $170.26 +1.60% 208.95B — 28.9% +2.6% 3.98% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $534.20 -0.67% 134.82B 33.9 32.9% +10.4% — Strong buy Compare
REGN Regeneron Pharmaceuticals $957.76 +0.56% 98.38B 20.4 31.4% +5.6% — Buy Compare
MRNA Moderna Inc $206.80 -3.93% 90.54B — -145.2% -53.4% — Hold Compare
NTRA Natera Inc $287.47 -0.35% 45.90B — -9.0% +41.1% — Strong buy Compare
RVMD Revolution Medicines Inc $162.69 -2.50% 37.37B — 4.4% +0.4% — Strong buy Compare
BIIB Biogen Inc $250.79 -0.34% 37.21B 107.1 13.1% -0.9% — Buy Compare
ROIV Roivant Sciences Ltd $38.71 +0.26% 28.64B — -3,629.2% -48.7% — Strong buy Compare
INSM Insmed Inc $121.86 -0.83% 25.90B — -210.5% +35.2% — Strong buy Compare
INCY Incyte Corp $119.09 -0.98% 24.53B 60.8 25.0% +14.8% — Hold Compare
UTHR United Therapeutics Corp $584.10 -0.64% 24.15B 19.6 41.9% +18.0% — Strong buy Compare
ALNY Alnylam Pharmaceuticals Inc $156.50 -2.02% 20.98B 7.7 8.5% +53.0% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $165.92 +0.37% 16.90B 24.1 16.7% +24.3% — Strong buy Compare
EXEL Exelixis Inc $68.50 +2.09% 16.88B 19.1 33.7% +12.9% — Hold Compare
BBIO Bridgebio Pharma Inc $76.80 -0.72% 15.27B — -144.4% +86.3% — Strong buy Compare
HALO Halozyme Therapeutics Inc $95.97 -0.55% 11.48B 27.8 22.7% +28.4% — Strong buy Compare
SMMT Summit Therapeutics Inc $10.67 -9.73% 11.32B — 15.4% -3.6% — Buy Compare